Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • lorendarith
    • Oct 2026

    #1

    Contaminants as a necessary evil?

    If you do any sort of adapter trimming (complete sequence, specific kmers, barcodes...) and completely make your data devoid of these sequences, wouldn't one also eliminate any actual biological sequence that bares resemblance to these contaminants?

    Wouldn't that cause a gap in the assemblies?

    Does any of this make sense? D:
  • mastal
    Senior Member
    • Mar 2009
    • 666

    #2
    Contaminants as a necessary evil?

    Yes, it makes sense.

    I guess when we do adapter trimming we are assuming that the adapters have been designed so that those sequences don't map anywhere in the genome.

    And there is obviously also a trade-off between removing all the contaminating adapter sequences and risking that in trimming too aggressively we will be removing some actual sequence that is not adapter.

    Comment

    • lorendarith

      #3
      Originally posted by mastal View Post
      I guess when we do adapter trimming we are assuming that the adapters have been designed so that those sequences don't map anywhere in the genome.
      Agreed, but I don't think there is a combination (of if there is prolly, not many possibilities?) of bases so the sequence doesn't turn up in one or the other genome.

      I tried blasting the first 25bp of the Illumina Truseq adapter against nt and you get quite some hits (genomes). Now, I don't know if the hits are actual biological sequences or leftover contaminants.

      One could test it against a Sanger sequenced genome...

      Comment

      • krobison
        Senior Member
        • Nov 2007
        • 734

        #4
        Most of the trimming you describe is applied only to the ends of reads, so the information will not be lost if it appears in the middle of reads.

        But, it is definitely true that you need to think carefully about what you are screening out entirely. You may lose something valuable!

        Comment

        • rskr
          Senior Member
          • Oct 2010
          • 249

          #5
          Yes and no. In theory you should be able to build a predictive model that accounts for a large percentage of your contaminants. IE if your adapter sequences matches at 18 bases and mismatches at three, then you could calculate the probability that it is an adapter vs. the alternative not an adapter, assuming an error rate of 95 percent in the sequencing.

          For many analysts analysis it doesn't matter, remapping for example, there is just a bunch of junk left over. Other times it only becomes a problem when it breaks things, for example when an assembly or mapping has millions of mappings in a single place and the algorithms developers didn't build the software to handle that situation. And the most interesting of course are when you get crazy small p-values in completely irrelevant genes.

          I think it is interesting to take common adapter sequences 454 for example and blast them against ncbi just to see what comes up.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
            by SEQadmin2



            NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection of antimicrobial...
            Today, 06:46 AM
          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 10-28-2026, 09:57 AM
          0 responses
          22 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-28-2026, 09:51 AM
          0 responses
          14 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-22-2026, 11:13 AM
          0 responses
          67 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-22-2026, 10:48 AM
          0 responses
          47 views
          0 reactions
          Last Post SEQadmin2  
          Working...